Kwak, C., Lee, J.K. and Ku, J.H. (2007) High-Dose Terazosin Therapy (5 mg) in Korean Patients with Lower Urinary tract Symptoms with or Without Concomitant Hypertension: A Prospective, Open-Label Study. Yonsei Medical Journal, 48, 994-1000. http://dx.doi.org/10.3349/ymj.2007.48.6.994

has been cited by the following article:

• TITLE: Plasma Kinetic Resection of Prostate Combined Terazosin for Treatment of BPH Patient with Coexisting Hypertension

  AUTHORS: Ming Zheng, Mingqiang Zeng, Chonghe Jiang, Jinyang Chen, Shuren Li, Jiaxin Wang

  KEYWORDS: Benign Prostatic Hyperplasia, Hypertension, Terazosin, Plasma Kinetic Vaporization of the Prostate

  JOURNAL NAME: Open Journal of Urology, Vol.4 No.5, May 28, 2014

  ABSTRACT: Objective: To evaluate the efficacy and safety of terazosin and plasma kinetic resection of the prostate (PKRP) in the treatment of benign prostatic hyperplasia (BPH) patients with coexisting hypertension. Methods: A total of 205 men who suffered from BPH with concomitant hypertension were enrolled in this study. They all received PKRP surgery and terazosin medication from one week before to 3 months after the operation. The procedures of efficacy and safety were evaluated by analysis of the changes in blood pressures, IPSS, Qmax and the drug related adverse events 4 weeks and 3 months after the operation. Results: The systolic blood pressure decreased from 161 ± 12.33 mmHg at baseline to 148 ± 7.27 mmHg four weeks (PPPPPPP